Multidrug-resistant tuberculosis and culture conversion with bedaquiline.

By A. Diacon, A. Pym, M. Grobusch, J. de los Ríos, E. Gotuzzo, I. Vasilyeva, V. Leimane, K. Andries, N. Bakare, T. De Marez and 6 more. New England Journal of Medicine, 2014

662 citations recorded by the source corpus.

Subfields: Infectious Diseases, Organic Chemistry, Surgery

View Paper: https://www.semanticscholar.org/paper/423dc87524acc738dbce42708bb55e0fe12492a0

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

1. I. Abubakar
2. Alimuddin Zumla
3. A. N. Bulabula
4. Fatima Razia
5. M. Khan
6. P. Katoto
7. S. Hasnain
8. Timothy D McHugh

Citations in the corpus

• Global Tuberculosis Report 2020 – Reflections on the Global TB burden, treatment and prevention efforts (2021, background): “Such regimens should be urgently scaled-up to improve outcomes, minimize side effects and improve adherence along with point-of-care molecular drug susceptibility testing of second line MDR-TB drugs (Bisimwa et al., 2020; Cox et al., 2018; Diacon et al., 2014; Gler et al., 2012).”